个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Jiang Nan[1] * ; Yang Pingting[2] * ; Liu Shengyun[3] * ; Li Hongbin[4] ; Wu Lijun[5] ; Shi Xiaofei[6] ; Fang Yongfei[7] ; Zhao Yi[8] ; Xu Jian[9] ; Jiang Zhenyu[10] ; Wu Zhenbiao[11] ; Duan Xinwang[12] ; Wang Qian[1] ; Tian Xinping[1] ; Li Mengtao[1,*1] ; Zeng Xiaofeng[1,*1] ;
机构： [1]Department of Rheumatology, Peking Union MedicalCollege Hospital, Peking Union Medical College andChinese Academy of Medical Sciences, KeyLaboratory of Rheumatology and ClinicalImmunology, Ministry of Education, Beijing, People’sRepublic of China [2]Department of Rheumatologyand Immunology, First Affiliated Hospital, ChinaMedical University, Shenyang, People’s Republic ofChina [3]Department of Rheumatology, The FirstAffiliated Hospital of Zhengzhou University,Zhengzhou, People’s Republic of China [4]Departmentof Rheumatology, Affiliated Hospital of InnerMongolia Medical College, Hohhot, Inner Mongolia,People’s Republic of China [5]Department ofRheumatology and Immunology, People’s Hospital ofXinjiang Uygur Autonomous Region, Urumqi,Xinjiang Uygur Autonomous Region, People’sRepublic of China [6]Department of Rheumatologyand Immunology, The First Affiliated Hospital, andCollege of Clinical Medicine of Henan University ofScience and Technology, Luoyang, Henan, People’sRepublic of China [7]Department of Rheumatology,Southwest Hospital, Third Military MedicalUniversity, Chongqing, People’s Republic of China [8]Department of Rheumatology and Immunology,West China Hospital, Sichuan University, Chengdu,People’s Republic of China [9]Department ofRheumatology and Immunology, First AffiliatedHospital of Kunming Medical University, Kunming,Yunnan, People’s Republic of China [10]Department ofRheumatology, The First Hospital of Jilin University,Changchun, Jilin, People’s Republic of China [11]Department of Clinical Immunology andRheumatology, Xijing Hospital Affiliated to the FourthMilitary Medical University, Shanxi, People’s Republicof China [12]Department of Rheumatology, TheSecond Affiliated Hospital of Nanchang University,Nanchang, Jiangxi, People’s Republic of China
出处：
DOI： 10.2147/PPA.S232578
ISSN：

关键词： patient physician rheumatoid arthritis treatment satisfaction TSQM-II

摘要：
Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by chronic destructive synovitis and possible multisystem involvement. This study aimed to survey the treatment satisfaction of physicians and patients with RA, and to explore the potential factors. This cross-sectional study was conducted in 12 centers across China between March 2018 and April 2018. The Treatment Satisfaction Questionnaire for Medication version II was used to assess the treatment satisfaction of patients and physicians. Multivariable regression analysis was used to determine the factors independently associated with treatment satisfaction of patients. The patients' satisfaction (n=335) with biological disease-modifying antirheumatic drugs (bDMARDs) was higher than physicians' satisfaction (n=146) regarding the side effects (95.0±14.3 vs 84.6±15.7, P<0.001) and convenience (74.6±21.2 vs 69.1±16.5, P=0.002). Among physicians, global satisfaction with bDMARDs was higher than that with conventional synthetic DMARDs (csDMARDs). The multivariable regression analysis showed that age was positively associated with satisfaction of patients, while college or above education and self-assessment of disease severity were inversely associated with satisfaction. Treatment satisfaction was associated positively with the quality of communication with the physician and inversely with treatment costs. For bDMARDs, the treatment satisfaction of patients with RA is generally higher than that of physicians'. Physicians' satisfaction with bDMARDs is higher than with csDMARDs. Age, education, disease severity, communication with the physician, and treatment costs are independently associated with the treatment satisfaction among patients. Physician-patient communication should be improved in clinical practice. Treatment costs should be taken into account when physicians make decisions. © 2020 Jiang et al.

基金：
This study was supported by the Chinese National Key Technology R&D Program (2017YFC0907601, 2017YFC0907604).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 4 区 医学
小类 | 3 区 医学：内科
最新[2023]版：
大类 | 3 区 医学
小类 | 3 区 医学：内科
JCR分区：
出版当年[2019]版：
Q2 MEDICINE, GENERAL & INTERNAL
最新[2023]版：
Q2 MEDICINE, GENERAL & INTERNAL

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者：
第一作者机构： [1]Department of Rheumatology, Peking Union MedicalCollege Hospital, Peking Union Medical College andChinese Academy of Medical Sciences, KeyLaboratory of Rheumatology and ClinicalImmunology, Ministry of Education, Beijing, People’sRepublic of China
共同第一作者：
通讯作者：
通讯机构： [1]Department of Rheumatology, Peking Union MedicalCollege Hospital, Peking Union Medical College andChinese Academy of Medical Sciences, KeyLaboratory of Rheumatology and ClinicalImmunology, Ministry of Education, Beijing, People’sRepublic of China [*1]Department of Rheumatology, Peking Union Medical College Hospital, No. 1 Shuaifuyuan, Wangfujing Ave,Beijing 100730, People’s Republic of China
推荐引用方式(GB/T 7714)：
Jiang Nan,Yang Pingting,Liu Shengyun,et al.Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.[J].PATIENT PREFERENCE AND ADHERENCE.2020,14:1037-1047.doi:10.2147/PPA.S232578.
APA：
Jiang Nan,Yang Pingting,Liu Shengyun,Li Hongbin,Wu Lijun...&Zeng Xiaofeng.(2020).Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China..PATIENT PREFERENCE AND ADHERENCE,14,
MLA：
Jiang Nan,et al."Satisfaction of Patients and Physicians with Treatments for Rheumatoid Arthritis: A Population-Based Survey in China.".PATIENT PREFERENCE AND ADHERENCE 14.(2020):1037-1047

相关文献

[1]Treatment satisfaction with rheumatoid arthritis in patients with different disease severity and financial burden: A subgroup analysis of a nationwide survey in China [2]Tocilizumab in rheumatoid arthritis‐associated peripheral ulcerative keratitis: A case report [3]Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis. [4]Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis [5]Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis. [6]An Interdigitated Aptasensor to Detect Interleukin-6 for Diagnosing Rheumatoid Arthritis in Serum. [7]Patient-Versus Physician-Perceptions of Symptoms, Treatment and Management in Chronic Myeloid Leukemia [8]Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients [9]Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis [10]Assessment of Thyroid Function in Patients with Rheumatoid Arthritis in Kunming, China: A Case-control Study

资源点击量：82584 今日访问量：0 总访问量：681 更新日期：2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西山区金碧路157号